Placement Announced
Avere Therapeutics placement
US$320m raised
Announced 14 Jul 2026
Advisers
Lead managers
- Legal adviser
- Cooley
Team: Denny Won, Charlie Kim, Div Gupta, Peter Haddad
- Placement agent
Investor
- Legal adviser
- Issuer
- Avere Therapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Electra Therapeutics IPO Sep 2026 · US$350m · Biotech
- Latigo Biotherapeutics IPO Aug 2026 · US$346m · Biotech
- Attovia Therapeutics IPO Aug 2026 · US$289m · Biotech
- Caldera Therapeutics placement Jul 2026 · US$278m · Biotech
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
Sources
- 14 Jul 2026 Avere Therapeutics Announces Merger Agreement With NextCure, Concurrent $320 Million Private Placement cooley.com
- 14 Jul 2026 Press release (GlobeNewswire), NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy globenewswire.com
- 15 Jul 2026 S&C Advises Hansoh Pharma on Exclusive License Agreement and Strategic Investment with Avere Therapeutics sullcrom.com
- 20 Jul 2026 Gibson Dunn Advises Avere Therapeutics on Reverse Merger with NextCure, and Concurrent Private Financing gibsondunn.com


